Trial intelligence / Profile preview

Constipation treatment added to propranolol for migraine in children with functional constipation

IRCT20120215009014N361Phase 2Completed

Sponsor
Hamadan University of Medical Sciences
Start
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of propranolol, macrogol 4000 and bisacodyl in migraine (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Rectal impaction. Started Mar 2020; status: completed.

02

Drugs

propranololmacrogol 4000bisacodyl
03

Conditions

migraine

Beyond the preview

Go deeper on IRCT20120215009014N361.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120215009014N361.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call